Evidence map›Paper›PMID 25744566›Full record

ReviewMolecular neurobiology2016

The Natural Flavonoid Pinocembrin: Molecular Targets and Potential Therapeutic Applications.

Xi Lan, Wenzhu Wang, Qiang Li, Jian Wang

Open access · greenAbstract readReview
In one paragraph

Review in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 144 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Inhibitory Effect ofInternational journal of molecular sciences · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Propolis and its therapeutic effects on renal diseases: A review.Iranian journal of basic medical sciences · 2024
    Review
  12. Inhibitory Effect of (2Advances in pharmacological and pharmaceutical sciences · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Optimization of Pinocembrin Biosynthesis inACS synthetic biology · 2023
    Article
  19. Review
  20. A study of the antibacterial mechanism of pinocembrin against multidrug-resistant Aeromonas hydrophila.International microbiology : the official journal of the Spanish Society for Microbiology · 2022
    Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xi LanDepartment of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, 720 Rutland Ave, Ross Bldg 370B, Baltimore, MD, 21205, USA.
Wenzhu WangDepartment of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, 720 Rutland Ave, Ross Bldg 370B, Baltimore, MD, 21205, USA.
Qiang LiDepartment of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, 720 Rutland Ave, Ross Bldg 370B, Baltimore, MD, 21205, USA.
Jian WangDepartment of Anesthesiology and Critical Care Medicine, The Johns Hopkins University School of Medicine, 720 Rutland Ave, Ross Bldg 370B, Baltimore, MD, 21205, USA. jwang79@jhmi.edu.
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Neuroprotective effect of flavanol (-) epicatechin after intracerebral hemorrhageR01AT007317 · NCCIH · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2012 to 2016
$2.0M
PGE2 EP1 and EP3 receptors as therapeutic targets in intracerebral hemorrhageR01NS078026 · NINDS · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2012 to 2016
$1.8M
Role of PGE2 receptors in the aging brain after intracerebral hemorrhageK01AG031926 · NIA · JOHNS HOPKINS UNIVERSITY · PI WANG, JIAN · 2008 to 2012
$536k
NCCIH NIH HHS R01 AT007317NCCIH NIH HHS R01AT007317NIA NIH HHS K01 AG031926NIA NIH HHS K01AG031926NINDS NIH HHS R01 NS078026NINDS NIH HHS R01NS078026
6 · The paper itself

Abstract

Pinocembrin is a natural flavonoid compound extracted from honey, propolis, ginger roots, wild marjoram, and other plants. In preclinical studies, it has shown anti-inflammatory and neuroprotective effects as well as the ability to reduce reactive oxygen species, protect the blood-brain barrier, modulate mitochondrial function, and regulate apoptosis. Considering these pharmaceutical characteristics, pinocembrin has potential as a drug to treat ischemic stroke and other clinical conditions. In this review, we summarize its pharmacologic characteristics and discuss its mechanisms of action and potential therapeutic applications.

Indexed as

AnimalsFlavanonesFlavonoidsHumansModels, BiologicalNeuroprotective AgentsFlavanonesFlavonoidsNeuroprotective AgentspinocembrinNeuroinflammationNeuroprotectionPinocembrinStroke

Identifiers

PMID25744566
PMCPMC4561606
OpenAlexW2113816263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.